Literature DB >> 1906363

[Contraceptive activity of RU486 and oral active prostaglandin combination].

E Aubeny1, E E Baulieu.   

Abstract

The most used medical method for early pregnancy interruption associates the antiprogestin RU486 (Mifepristone) and an intramuscularly injected prostaglandin (Sulprostone) (Silvestre et al., New Engl. J. Med., 322, 1990, pp. 645-648). Misoprostol, an orally active PGE1 synthetic derivative, showed the same efficacy as Sulprostone in a trial including 100 patients. The medical characteristics and potential of the new method are briefly discussed.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1906363

Source DB:  PubMed          Journal:  C R Acad Sci III        ISSN: 0764-4469


  5 in total

Review 1.  Mifepristone. Separating fact from fiction.

Authors:  R C Henshaw; A A Templeton
Journal:  Drugs       Date:  1992-10       Impact factor: 9.546

Review 2.  Nongenomic action of steroids in myometrial contractility.

Authors:  M Perusquía
Journal:  Endocrine       Date:  2001-06       Impact factor: 3.633

Review 3.  Mifepristone. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential.

Authors:  R N Brogden; K L Goa; D Faulds
Journal:  Drugs       Date:  1993-03       Impact factor: 9.546

Review 4.  Misoprostol to prevent and treat postpartum haemorrhage: a systematic review and meta-analysis of maternal deaths and dose-related effects.

Authors:  G Justus Hofmeyr; A Metin Gülmezoglu; Natalia Novikova; Verena Linder; Sandra Ferreira; Gilda Piaggio
Journal:  Bull World Health Organ       Date:  2009-09       Impact factor: 9.408

Review 5.  Antiprogestin pharmacodynamics, pharmacokinetics, and metabolism: implications for their long-term use.

Authors:  G R Jang; L Z Benet
Journal:  J Pharmacokinet Biopharm       Date:  1997-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.